Michel Habib
Co-Founder & Managing General Partner @ ALIVE Israel HealthTech Fund
Tel Aviv, Israel
Michel Habib is a Series A investor at ALIVE Israel HealthTech Fund in Tel Aviv focused on Medical and Health Care. Managing partner at Agate Venture, Founder & CEO Matar Capital Advisors. Former Director Business Development, Elron Electronic Industries, part of the IDB group (NASDAQ ELRN). Led Elron's Medical Device sector investments, served on the BOD of Elbit Vision Systems, Nulens, AMT, 3DV Systems & others. Former Head of investmentbanking Israel at ING Barings, the investment banking arm of ING Group. Vice President Investment Banking, Cukierman & Co., where he managed private placements and IPOs in Europe. Israel's Economic Consul in Boston, & Commercial Attache to South Korea. B.Sc. in Aeronautical Engineering from the Technion - Israel Institute of Technology. Member of the Technion Alumni 100 Club.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Michel Habib invests in
Stages Michel Habib invests in
Countries Michel Habib invests in
Investment Focus
Industry
- Medical 2 (50%)
- Health Care 2 (50%)
- Apps 1 (25%)
- Mobile 1 (25%)
- Internet 1 (25%)
Stage
- Series A 1 (25%)
- Series C 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Israel 2 (50%)
- Switzerland 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Wisdo Health
|
Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health. | $5M / Series A / Jan 05, 2023 | |
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $46.5M / Venture - Series Unknown / Jun 16, 2021 | |
|
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $18M / Venture - Series Unknown / Feb 25, 2020 | |
SENSIMED
|
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best beused in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland. | Series C / Oct 09, 2012 |
Co-Investors
About ALIVE Israel HealthTech Fund
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
ALIVE Israel HealthTech Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ari Shamiss
Co-Founder and Managing General Partner
|
|||
Dudi Klein
Co-Founder and Managing Partner
|
|||
Dudi Klein
Co-Founder and Managing Partner
|
|||
|
Michel Habib
Co-Founder & Managing General Partner
|
|||
Prof. Rafael Beyar
Co-Founder and Managing General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Michel Habib invest in?
Michel Habib invests primarily in Medical, Health Care and Apps startups, most often at Series A and Series C stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Michel Habib last invest?
The most recent investment recorded for Michel Habib closed in Jan 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
